Lobbying

America's Physician Groups's latest lobbying report covers Q2 2026, at $110K. The four quarters Q4 2025–Q3 2026 total $430K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.

America's Physician Groups

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$430K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

America's Physician Groups lobbying by quarter
America's Physician Groups lobbying by quarter
QuarterAmountReports
Q4 2022$150K1
Q1 2023$150K1
Q2 2023$90K1
Q3 2023$170K1
Q4 2023$200K1
Q1 2024$280K1
Q2 2024$280K1
Q3 2024$280K1
Q4 2024$160K1
Q1 2025$160K1
Q2 2025$160K1
Q3 2025$160K1
Q4 2025$160K1
Q1 2026$160K1
Q2 2026$110K1
Q3 2026$00

By issue

  • Medicare and Medicaid$2.3M · 14 reports
  • Health issues$410K · 4 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Executive Office of the President (EOP)2 reports
  • Homeland Security, Dept of (DHS)1 reports

Firms it paid

Firm
In-houseAmerica's Physician Groups$2.7M15 quarters

Former officials lobbying for it

Former position
VALINDA RUTLEDGESenior Advisor and Group Director, Center for Medicare and Medicaid Services Innovation (CMMI)Q3 2023

Lobbying reports

Filed by
07/20for Q2In-house$110K
04/20for Q1In-house$160K
01/20for Q4 2025In-house$160K
25/10/20for Q2 2025In-house$160K
25/10/20for Q1 2025In-house$160K
25/10/20for Q3 2025In-house$160K
25/07/21for Q2 2025In-house$110K
25/04/21for Q1 2025In-house$110K
25/01/21for Q4 2024In-house$160K
24/10/21for Q3 2024In-house$280K
24/07/22for Q2 2024In-house$280K
24/04/22for Q1 2024In-house$280K
24/01/22for Q4 2023In-house$200K
23/10/20for Q3 2023In-house$170K
23/07/20for Q2 2023In-house$90K
23/04/20for Q1 2023In-house$150K
23/02/24for Q4 2022In-house$150K
23/01/20for Q4 2022In-house$150K